Baijin Life Science Holdings Limited
MNNGFOTCHealthcare● Active
$0.08
+$0.00(+0.00%)
Market Cap$58003000
P/E Ratio—
52W High$0.08
52W Low$0.045
Baijin Life Science Holdings Limited（MNNGF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MNNGF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.14B | $0.05B | $0.09B | $0.06B | $0.04B |
| Cost of Revenue | $0.09B | $0.04B | $0.08B | $0.05B | $0.05B |
| Gross Profit | $0.04B | $0.02B | $0.01B | $0.01B | ($0.01B) |
| Gross Margin %(computed) | 30.97% | 33.72% | 9.01% | 17.55% | -19.90% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.03B | $0.03B | $0.02B | $0.01B | $0.02B |
| Total Operating Expenses | $0.04B | $0.03B | ($0.00B) | $0.02B | $0.03B |
| Operating Income | ($0.00B) | ($0.01B) | $0.01B | ($0.01B) | ($0.05B) |
| Operating Margin %(computed) | -1.47% | -17.84% | 10.98% | -17.70% | -109.96% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.01B) | $0.01B | ($0.02B) | ($0.05B) |
| Income Tax Expense | ($0.00B) | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Income | ($0.00B) | ($0.01B) | $0.01B | ($0.02B) | ($0.05B) |
| Net Margin %(computed) | -0.23% | -13.88% | 9.99% | -24.68% | -119.53% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.01 | $0.01 | $-0.04 | $-0.22 |
| Wtd Avg Shares | 0.69B | 0.65B | 0.60B | 0.37B | 0.24B |
| EBITDA | $0.01B | ($0.01B) | $0.01B | ($0.01B) | ($0.05B) |
| EBITDA Margin %(computed) | 4.62% | -11.78% | 12.87% | -15.53% | -104.91% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · HKD · B
深入了解Baijin Life Science Holdings Limited
关于Baijin Life Science Holdings Limited（MNNGF）损益表
Baijin Life Science Holdings Limited（MNNGF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，MNNGF实现营收$0.14B，毛利润$0.04B（毛利率30.97%），净利润($0.00B)（净利率-0.23%）。
常见问题
MNNGF · 4 问Baijin Life Science Holdings Limited（MNNGF）2025财年营收为$0.14B，同比up152.5%。
MNNGF revenueMNNGF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09